Home » Topics » BioWorld Science

BioWorld Science
RSS

Atreca announces agreement with Zymeworks and selection of new clinical candidate

April 6, 2022

PEAR1 genetic variation tied to big endothelin levels in patients with acute myocardial infarction

April 6, 2022

New SPNS2 inhibitors synthesized by University of Virginia

April 6, 2022

Schroedinger identifies new CDC7 inhibitors

April 6, 2022

Gasherbrum Bio presents new GLP-1 receptor agonists

April 6, 2022

New HBV antiviral compounds patented by Janssen

April 6, 2022

Shaanxi Micot Technology discloses new CaSR agonists

April 6, 2022

OPG is an independent factor for coronary artery calcification in hypertension

April 6, 2022

Elevated troponin in patients with COVID-19 is an independent risk factor for mortality

April 6, 2022

NUAK1 inhibition as new antifibrotic treatment strategy

April 6, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...